Enhancing Care Foundation
Enhancing Care Foundation is a South African not-for-profit clinical research organisation that designs and manages Phase II-IV trials in HIV, TB, vaccines, and women's health across three KwaZulu-Natal sites, funded by NIH, Global Fund, World Bank, and EU grants.
- Company typePrivate
- Founded2007
- HeadquartersMount Edgecombe, South Africa
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Enhancing Care Foundation does
Enhancing Care Foundation (ECF) is a South African not-for-profit clinical research organisation headquartered in Mount Edgecombe, KwaZulu-Natal, that designs and manages Phase II to Phase IV clinical trials and implementation science studies in HIV/AIDS, tuberculosis, vaccine development, women's health, COVID-19 therapeutics, and non-communicable diseases. The organisation operates three physical sites — Mount Edgecombe Research Centre (administrative and operational headquarters), Victoria Mxenge Hospital Research Unit (clinical research facility with data management and satellite pharmacy), and Wentworth Hospital Research Site (outpatient/inpatient research) — staffed by a 40-person multi-disciplinary team of project managers, quality controllers, M&E specialists, social scientists, and medical experts. ECF's leadership team has independently retained both a Paediatric and an Adult AIDS Clinical Trials Unit (ACTU) since 2007, providing embedded access to NIH/NIAID ACTG and IMPAACT networks, and the co-founders Dr Sandy Pillay and Dr Rosie Mngqibisa hold senior protocol-level positions across these networks. Technical infrastructure centres on clinical trial management systems, NIH-funded clinical research platforms, and data management systems supporting multi-country protocols; the ENABLE project (launched January 2026) extends research into broadly neutralizing antibody therapeutics for infants with HIV across South Africa, Mozambique, and Cameroon.
ECF operates as a grant-funded organisation rather than a commercial enterprise; revenue flows from research grants and partnerships with NIH, Global Fund, World Bank, and the European Union (EDCTP3). Go-to-market is partnership-led: ECF is integrated into international clinical trial consortia (e.g., as 1 of 21 ENABLE partners), embedded in South African public health structures (National Department of Health, KwaZulu-Natal Department of Health, eThekwini Health District), and collaborates with academic institutions including UCSD Clinical Trials Unit, University of KwaZulu-Natal, and Wits Research Hub. Service offerings span clinical trial execution, capacity building (including South Africa's first coursework postgraduate diploma in clinical HIV management at UKZN), health system strengthening programmes (TB in the Mining Sector, cross-border TB harmonisation), research environment support, and a growing eLearning course portfolio for healthcare workers and policymakers. Customer segments are use-case based: research institutions and healthcare providers, government health departments, and communities/civil society across KwaZulu-Natal and selected African countries, with no traditional commercial customer relationship.
Enhancing Care Foundation firmographics
Firmographics- Name
- Enhancing Care Foundation
- Legal name
- Enhancing Care Foundation
- Website
- https://ecarefoundation.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Enhancing Care Foundation is a South African not-for-profit clinical research organisation that designs and manages Phase II-IV trials in HIV, TB, vaccines, and women's health across three KwaZulu-Natal sites, funded by NIH, Global Fund, World Bank, and EU grants.
- Ownership category
- akta.pro rank
Enhancing Care Foundation industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Voluntary Health Organizations (813212), Research and Development in the Social Sciences and Humanities (54172)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)
- akta.pro secondary industries
- HIV/AIDS Medicine (HLAKAGAB), Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN), Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs) (BPADAIAA), Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE), Infectious Disease & Immunization Program Funding (HLAJALAH), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL)
Keywords
Where Enhancing Care Foundation is headquartered
LocationHeadquarters
- HQ city
- Mount Edgecombe
- HQ country
- South Africa
- HQ region
- Africa
Offices3 records
Markets served
Enhancing Care Foundation business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Others, Marketing or Sales, Technology or R&D
Distribution channels3 records
Marketing channels4 records
Enhancing Care Foundation product offering
Product offeringCore offering
Enhancing Care Foundation is a South African not-for-profit clinical research organisation that designs and manages Phase II to Phase IV clinical trials and implementation science studies — primarily NIH-funded HIV and TB trials — delivered across three research sites in KwaZulu-Natal. Its offering extends beyond trial delivery to include health system strengthening programs (e.g., TB in the Mining Sector), capacity building and training for healthcare professionals (including eLearning), research environment support (study design, data management, regulatory assistance), and multi-site international research collaborations such as the ENABLE project on broadly neutralizing antibodies in infants with HIV.
Product overview
Enhancing Care Foundation offers an integrated portfolio of clinical research and health system strengthening services. The core offerings include Clinical & Non-Clinical Research (Phase II-IV trials and implementation science), HIV & TB Clinical Trials, Capacity Building & Training programs, Health System Strengthening initiatives, Research Environment Support, and eLearning Courses. The ENABLE Project represents a major new research initiative focused on broadly neutralizing antibody treatments for infants with HIV. These services work together to deliver comprehensive research services spanning study design and implementation to capacity building and ongoing health system support, all focused on HIV/AIDS, TB, and related conditions across Africa.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical & Non-Clinical Research
Quantifiable outcome
- 71% viral suppression rate achieved at 49 weeks in heavily treatment-experienced HIV-1 patients
- +1 more outcomes
Companies that use Enhancing Care Foundation
Customer profileSegments3 records
Ideal customer profiles3 records
Enhancing Care Foundation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Enhancing Care Foundation partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, flagship and minor.
- Servicio Madrileño de Salud (SERMAS) / Hospital Universitario 12 de OctubrecoreSERMAS and Hospital Universitario 12 de Octubre in Madrid, Spain serve as the coordinating body for the ENABLE project. They lead the consortium management and are ECF's primary coordination partners in this international research initiative.
- ENABLE Consortium (21 partners across Africa, Europe, and the United States)flagshipENABLE (Early Neutralizing Antibodies in Infants Living with HIV to Enhance their Life) is a four-year international research project funded by Global Health EDCTP3 and the European Union (GA 101190620). The project investigates whether broadly neutralizing antibodies (bNAbs) added to antiretrovirals can help achieve earlier viral control in infants diagnosed with HIV. Clinical trials are led in South Africa, Mozambique and Cameroon. ECF is one of 21 partners contributing to this initiative.
- National Department of Health (NDOH)coreECF maintains a longstanding relationship with the National Department of Health serving as a cornerstone of collaborative work. This partnership reflects shared commitment to improving health outcomes through evidence-based interventions, research, and health systems strengthening.
- KwaZulu-Natal Department of HealthcoreECF operates with support from KwaZulu-Natal Department of Health and has established a significant footprint across the province, working closely with provincial and district health structures to ensure research activities remain responsive to local health priorities.
- eThekwini Health DistrictcoreECF has developed strong partnerships with the eThekwini Health District, healthcare facilities, programme managers, and frontline healthcare workers. These relationships support research implementation, participant recruitment, health promotion, and translation of scientific evidence into improved healthcare delivery.
- NIH/NIAID AIDS Clinical Trials Group (ACTG)flagshipECF maintains formal collaboration with NIH/NIAID ACTG network. Dr Constance Benson serves as Principal Investigator and Chair of the Executive Committee and Vice Chair of the Scientific Steering Committee of the ACTG. This partnership enables ECF's leadership team to participate in international clinical trials and access NIH funding.
- NIH/NIAID International Maternal, Paediatric and Adolescent AIDS Clinical Trials (IMPAACT)coreECF collaborates with IMPAACT network for maternal and paediatric HIV research. The Durban International Clinical Trials Unit (DICTU) was funded by NIH through both ACTG and IMPAACT groups, supporting ECF's involvement in adolescent and paediatric HIV studies.
- University of California, San Diego (UCSD) Clinical Trials UnitcoreECF operates through the Durban International Clinical Research Site (DICRS), a division of UCSD's Clinical Trials Unit. Dr Pillay continues involvement as Investigator in DICRS, participating in various protocol teams for HIV and TB research.
- University of KwaZulu-Natal (UKZN)coreECF co-founder Dr Pillay developed South Africa's only coursework postgraduate program in clinical HIV management at UKZN and coordinated clinical HIV services. ECF maintains collaborative relationships with UKZN for research and academic initiatives.
- Wits Research HubminorECF collaborates with Wits Research Hub on vaccine research and development, working in partnership on innovative therapeutic approaches.
- eThekwini AIDS Council and District AIDS CouncilscoreECF works closely with eThekwini AIDS Council and District AIDS Councils to strengthen public participation in research and healthcare programmes, supporting community engagement and stakeholder coordination.
- KwaZulu-Natal Civil Society Sector and Community-Based OrganisationscoreECF partners with civil society organisations and community-based organisations throughout KwaZulu-Natal to extend research reach, support participant engagement, and promote health promotion activities at community level.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Enhancing Care Foundation competitors and assessment
Company assessmentDirect peers
- Aurum Institute: South African health research organisation delivering TB, HIV, and COVID-19 clinical trials and implementation science with significant NIH and PEPFAR funding; comparable in scale, disease focus, and grant-funded clinical research model.
- CAPRISA (Centre for the AIDS Programme of Research in South Africa): South Africa-based HIV/TB clinical research organisation running NIH-funded trials and treatment optimisation studies; directly comparable to ECF in disease focus, funder base, and academic medical-centre affiliation (University of KwaZulu-Natal).
- Wits RHI (Wits Reproductive Health and HIV Institute): University of the Witwatersrand-affiliated research institute running HIV prevention and treatment trials in South Africa and the region; comparable to ECF as an academic-anchored, NIH-funded HIV clinical trials unit.
- Desmond Tutu Health Foundation: Cape Town-based HIV/TB prevention and treatment research NGO with deep NIH and Gates Foundation ties; closely comparable to ECF as a Southern African nonprofit clinical research platform focused on HIV/TB and health system strengthening.
- MRC Clinical Trials Unit at UCL: UK-based academic clinical trials unit running multi-country HIV, TB, and infectious disease trials; comparable in delivering large, multi-site Phase II–IV trials with similar operational and methodological rigour.
Regional players
- ANRS Emerging Infectious Diseases / France REcherche Nord&Sud Sida-HIV Hépatites: French-funded HIV/HCV research agency running multi-country trials in Africa including South Africa; comparable as a publicly funded HIV clinical research sponsor coordinating international African trial sites.
Broad incumbents
- South African Medical Research Council (SAMRC): South Africa's national health research council funding and conducting health research including HIV/TB; broader in scope than ECF but operates in the same national health research ecosystem.
- International AIDS Vaccine Initiative (IAVI): Global nonprofit advancing HIV vaccine and antibody research with significant African trial footprint; adjacent peer given ECF's emerging antibody-based paediatric HIV work (ENABLE) and vaccine evaluation remit.
- HIV Prevention Trials Network (HPTN): NIH-funded global clinical trials network conducting HIV prevention research across multiple continents; ECF participates in adjacent NIH-funded trial networks and serves as a site for similar protocols.
- University of California, San Diego (UCSD) Clinical Trials Unit: ACTG-affiliated US clinical trials unit that operates DICRS in Durban; directly comparable in NIH/ACTG protocol delivery, with overlapping investigator relationships to ECF leadership.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Enhancing Care Foundation social profiles
Digital presenceEnhancing Care Foundation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Enhancing Care Foundation leadership team
Management profileNumber of profiles
Profiles2 records
Enhancing Care Foundation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Enhancing Care Foundation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Enhancing Care Foundation
What does Enhancing Care Foundation do?
Enhancing Care Foundation is a South African not-for-profit clinical research organisation that designs and manages Phase II to Phase IV clinical trials and implementation science studies — primarily NIH-funded HIV and TB trials — delivered across three research sites in KwaZulu-Natal. Its offering extends beyond trial delivery to include health system strengthening programs (e.g., TB in the Mining Sector), capacity building and training for healthcare professionals (including eLearning), research environment support (study design, data management, regulatory assistance), and multi-site international research collaborations such as the ENABLE project on broadly neutralizing antibodies in infants with HIV.
Is Enhancing Care Foundation a public or private company?
Enhancing Care Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Enhancing Care Foundation founded?
Enhancing Care Foundation was founded in 2007. It employs 11 to 50 people.
Where is Enhancing Care Foundation based?
Enhancing Care Foundation is headquartered in Mount Edgecombe, South Africa, in the Africa region.
Who are Enhancing Care Foundation's main competitors?
Direct peers on record are Aurum Institute, CAPRISA (Centre for the AIDS Programme of Research in South Africa), Wits RHI (Wits Reproductive Health and HIV Institute), Desmond Tutu Health Foundation and MRC Clinical Trials Unit at UCL. ANRS Emerging Infectious Diseases / France REcherche Nord&Sud Sida-HIV Hépatites is listed as a regional player. Broad incumbents are South African Medical Research Council (SAMRC), International AIDS Vaccine Initiative (IAVI), HIV Prevention Trials Network (HPTN) and University of California, San Diego (UCSD) Clinical Trials Unit.
Does Enhancing Care Foundation have an API?
No public API is recorded for Enhancing Care Foundation.
What industry is Enhancing Care Foundation in?
Enhancing Care Foundation's product category is Clinical Research Services. Its primary akta.pro industry code is HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs), with a secondary code of HLAKAGAB, HIV/AIDS Medicine. Its NAICS code is 5417 and its SIC code is 8731.